Status:
COMPLETED
Ending Transmission of HIV, HCV, and STDs and Overdose in Rural Communities of People Who Inject Drugs (ETHIC)
Lead Sponsor:
University of Chicago
Collaborating Sponsors:
Southern Illinois University
Community Action Place, Inc.
Conditions:
HIV
Hepatitis C
Eligibility:
All Genders
15+ years
Phase:
NA
Brief Summary
This study will evaluate the referral to harm reduction services (HRS) including syringe services, naloxone overdose prevention, substance use treatment referral, HIV, HCV, and STD testing and referra...
Detailed Description
This is a prospective longitudinal Type 1 Hybrid Implementation Effectiveness Study on the expansion of harm reduction services for people who inject drugs (PWID) and people who use opioids (PWUO) res...
Eligibility Criteria
Inclusion
- 15 years of age and older
- Injected any drug in the past 30 days
- Used any opioids non-medically in the past 30 days
- English speaking
- Able to provide informed consent at the time of the study visit
Exclusion
- Less than 15 years of age
- Not injected any drug in the past 30 days
- Not used any opioids non-medically in past 30 days
- Non-English speaking
- Has not injected any opioid drug to get high in the past 30 days
- Unable to provide informed consent at the time of the study visit
Key Trial Info
Start Date :
August 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 16 2023
Estimated Enrollment :
306 Patients enrolled
Trial Details
Trial ID
NCT04427202
Start Date
August 14 2020
End Date
August 16 2023
Last Update
December 12 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Southern Illinois University
Carbondale, Illinois, United States, 62901
2
The Community Action Place, Inc.
Murphysboro, Illinois, United States, 62966